PRESS RELEASES & STATEMENTS

      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 5 December, 2018

    2018 ISSCR Year in Review

    Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 November, 2018

    New Perspectives in Stem Cell Reports

    In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.
    Full story
      • 12 November, 2018

    Convergence of Stem Cell Science and Medicine

    Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story
      • 5 October, 2018

    Developing Trainees, Expanding Horizons

    I take seriously my responsibility to support and nurture future generations of stem cell scientists. Indeed, it is critical for all of us in this evolving field to help trainees and others coming up in the field, to ensure they have opportunities to learn, grow, make connections, and share their science.
    Full story
      • 2 October, 2018

    ISSCR Comments on Horizon Europe

    The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.
    Full story
      • 2 October, 2018

    ISSCR Voice is Heard on Capitol Hill

    In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.
    Full story
      • 27 September, 2018

    ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research

    The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.
    Full story
      • 10 September, 2018

    ISSCR Journal Focuses on Women in Stem Cell Science; Reflections by CEO Nancy Witty

    The ISSCR has always had strong female leaders, and many of them are featured in the September and October editions of Stem Cell Reports.
    Full story
      • 6 September, 2018

    Energizing for Renewed Focus

    Many of us find time in the summer to reflect on work and recharge our batteries. Vacations, visits with friends, and time with family all help get away from everyday concerns in the lab and gain some perspective to inform the scientific path for the year ahead.
    Full story
      • 23 August, 2018

    Nominate for ISSCR Awards and Leadership Positions

    The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story
      • 17 July, 2018

    2018 ISSCR Annual Meeting Wrap-up

    The ISSCR 2018 Annual Meeting went “down under” to Melbourne, Australia where 3,000 stem cell scientists, clinicians, and professionals from 52 countries gathered to share their latest research, network with colleagues, and explore the latest technologies driving the field forward.
    Full story
      • 22 June, 2018

    Douglas A. Melton Becomes President of the ISSCR

    The ISSCR is pleased to announce Douglas A. Melton, PhD, Harvard University, as the incoming president of the ISSCR and its board of directors. Melton assumed the post on 23 June, 2018, immediately following the 16th ISSCR Annual Meeting in Melbourne, Australia.
    Full story
      • 20 June, 2018

    ISSCR Announces New Editor-in-chief for Stem Cell Reports Journal

    The ISSCR has appointed Martin F. Pera, professor at the Jackson Laboratory, U.S., as the next editor-in-chief of Stem Cell Reports, the organization’s open-access journal. Pera will succeed Christine Mummery, who led the journal since its launch in 2013. Pera will assume the post in January, 2019.
    Full story
      • 14 June, 2018

    ISSCR Opposes Proposal to Restrict Fetal Tissue Research

    The ISSCR opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released a statement on the issue.
    Full story
      • 23 May, 2018

    ISSCR Announces Hamburg, Germany as Site of 2021 Annual Meeting

    The ISSCR will hold its 2021 annual meeting in Hamburg, Germany, the first time the organization will be meeting in that city. The meeting is expected to draw 4,000 stem cell researchers and professionals from around the globe to the Congress Center Hamburg, scheduled to open in 2019. The meeting will be held 23-26 June, 2021.
    Full story
      • 4 June, 2018

    ISSCR Responds to President Trump Signing 'Right to Try' Law

    The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
    Full story
      • 10 May, 2018

    ISSCR Applauds Federal Injunctions Against Stem Cell Clinics

    The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation.
    Full story
      • 7 May, 2018

    Active Support for Stem Cell Research Around the World

    Scientific progress requires that legislators and regulators around the world recognize and appreciate the value of research and actively support pro-science policies. The ISSCR, through its policy program, champions the advancement of stem cell research and its translation to medicine.
    Full story
      • 30 April, 2018

    ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine

    Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.
    Full story
      • 26 April, 2018

    ISSCR Applauds Australia’s Move to Regulate Autologous Human Cell and Tissue Products

    The ISSCR appreciates the new framework proposed by Australia’s Therapeutic Goods Administration (TGA) for the regulation of human cell and tissue products that use a person’s own cells (‘autologous use’).
    Full story
      • 19 April, 2018

    ISSCR Advocates for Stem Cells and Basic Research in Europe

    ISSCR members and staff met 12 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation.
    Full story
      • 9 April, 2018

    Collaborations for Improving Human Health

    Like many stem cell researchers, my work is increasingly focused on developing ways to translate basic scientific discovery into treatments that help people suffering from disease or injury. The potential for stem cell therapies initially fascinated me as a developmental biologist, and over time I’ve learned the very real impact that our science can have on human health.
    Full story
      • 3 April, 2018

    ISSCR Advocates for Science Investment in Letter to European Commission

    In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe.
    Full story
      • 21 March, 2018

    Media Registration Open for ISSCR 2018 20-23 June, Melbourne, AUS

    Credentialed reporters can register and attend the 2018 annual meeting in Melbourne, Australia. They will have access to the many stem cell researchers and clinicians from around the world who will be discussing recent findings and progress that is driving development of stem cell treatments and cures for disease.
    Full story
      • 14 March, 2018

    ISSCR Announces Recipients of 2018 Awards

    Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.
    Full story
      • 12 March, 2018

    'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed

    The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.
    Full story
      • 12 March, 2018

    ISSCR 2018 Election Results

    The ISSCR is pleased to announce the results of its 2018 leadership election. On behalf of all members, we extend congratulations to newly-elected officers and board members.
    Full story
      • 12 March, 2018

    Scientific Excellence at ISSCR 2018

    Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.
    Full story
      • 15 February, 2018

    ISSCR Releases Guidebook to Evaluate Cell Therapy Trials

    The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.
    Full story
      • 9 February, 2018

    Showcasing Inspiring Science and Natural Beauty

    There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
    Full story
      • 7 February, 2018

    Stem Cell Reports Seeking Editor-in-Chief

    The ISSCR’s official journal, Stem Cell Reports, is seeking applications for a new Editor-in-Chief to succeed Christine Mummery, who has served in that role since the journal's inception in 2012.
    Full story
      • 17 January, 2018

    ISSCR Members Asked to Vote for Future Leaders

    The election is open for several ISSCR leadership posts, and members and trainee members are eligible to cast ballots in the election. Voting closes 5 February, 2018.
    Full story
      • 9 January, 2018

    ISSCR 2018: Stem Cells Down Under

    Stem cell research has led to profound insights into how developmental processes work in plants, animals, and humans. Increasingly, our work has shed light on how different life forms begin, develop, mature, and respond to injury and age. Myriad advances continue to contribute to understanding biology, cell function, disease and its treatment, senescence, and end of life.
    Full story
      • 4 January, 2018

    ISSCR Announces Two New Science Communications & Education Managers

    The ISSCR has selected Christopher Barry, PhD, and Julie Perlin, PhD, to be Science Communications & Education Managers, beginning 3 January, 2018.
    Full story
      • 4 January, 2018

    ISSCR Remembers Hiromitsu “Hiro” Ogawa

    The ISSCR is saddened by the passing of Hiromitsu “Hiro” Ogawa, a generous and thoughtful man who was a great supporter of stem cell science and the ISSCR.
    Full story
      • 11 December, 2017

    ISSCR Announces New Policy Director, Eric Anthony

    The ISSCR has named Eric Anthony to be its new Director of Policy. Anthony served more than eight years as staff in the U.S. Congress, most recently as legislative director for Congresswoman Rosa DeLauro of Connecticut. He will join the Society in early January 2018.
    Full story
      • 8 December, 2017

    The ISSCR Remembers Ihor Lemischka

    The ISSCR joins the stem cell community in expressing sadness at the passing of Ihor Lemischka, PhD, Professor of Developmental and Regenerative Biology, Pharmacology and Systems Therapeutics at the Icahn School of Medicine.
    Full story
      • 6 December, 2017

    Message from the President: 2017 Year in Review

    The ISSCR celebrated its 15th year as a global voice for stem cell research, and our efforts and activities in 2017 reflect the key role the society plays in advancing the field. We advocated on behalf of members in the policy and regulatory arenas, provided resources for the public, and continued to provide a global forum for scientists to gather and share research.
    Full story
      • 6 December, 2017

    Registration, Abstract Submissions Open for ISSCR 2018

    The ISSCR annual meeting is the world’s largest gathering of stem cell scientists, and in 2018 the meeting will be held in Melbourne, AU, 20-23 June, at the Melbourne Convention & Exhibition Centre. The meeting brings together some 3500 stem cell researchers and clinicians from around the world to share the latest developments in stem cell research and regenerative medicine.
    Full story
      • 17 November, 2017

    ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products

    The ISSCR commends the U.S. Food and Drug Administration (FDA) for reaffirming its regulatory authority over stem cell biologics and clarifying the criteria that determine which cell-based products fall under its oversight. These guidance documents will provide greater transparency for patients, medical professionals, and law enforcement authorities, about the legal status of stem cell treatments in the U.S.
    Full story
      • 10 October, 2017

    Celebrating Stem Cell Awareness Day, 11 October, 2017

    Each year, Stem Cell Awareness Day is an opportunity to reflect on the scientific advances and discoveries that are rapidly moving the field forward, with implications for the future of regenerative medicine and human health.
    Full story
      • 5 October, 2017

    ISSCR President Writes in Support of Fetal Tissue Research

    In an opinion editorial published today, the president of the ISSCR, Hans Clevers, underscores the importance of fetal tissue research. “Fetal tissue has been essential in research used to develop therapies that have saved millions of lives, and it continues to be necessary for the future of medicine,” he writes.
    Full story
Anne-AM17

Anne Nicholas

Director of Communications +1 847-929-4818 (o) +1 202-746-0866 (m)

Email Anne Nicholas